An independent directory of US medical spas
Treatment

Cheek, chin, jawline and temple filler: which products the FDA has approved for each area

Filler is approved by product and by area. The FDA's approval record lists the products approved for the cheeks, chin, jawline and temples, the year of each, the temple training requirement, and the risks.

At a glance

Approved by
Product and area
Ask whether yours is approved for the area.
Age
Adults 22 and older
The FDA's consumer update. Its record says over 21 for most.
Temple filler
Trained providers only
For Restylane Contour, in the FDA's September 2026 labeling.
Most serious risk
Filler in a blood vessel
Low chance. Can cause tissue death, stroke or blindness.

Filler is approved by product and by area. The FDA's approval record names the products approved for the cheeks, chin, jawline and temples, with the year of each.1 Ask which one is offered and whether it is approved for the area.

Here is what the record lists, the temple training rule and the risks. It gives no dose and no technique. Whether to have filler is for you and a clinician.

Cheeks

Juvederm Voluma XC was approved in 2013 for cheek augmentation to correct age-related volume loss in the midface. Restylane Lyft followed in 2015 for the cheeks and midface contour, with cannula use added in 2018. Restylane Contour was approved for the cheeks in 2021, and RHA 4 and RHA Dynamic Volume in 2025.1 The FDA also lists Sculptra, approved in 2023 for fine lines and wrinkles in the cheek region in people with a healthy immune system, and Bellafill, approved in 2014 for acne scars on the cheek.1

Chin

Voluma XC added the chin in 2020, to improve the chin profile. Restylane Defyne was approved for the chin in 2021, and Restylane Lyft in 2025, for people with mild to moderate chin retrusion, meaning a chin set back.1

Jawline

Radiesse (+) was approved in 2021 for moderate to severe loss of jawline contour, and Juvederm Volux XC in 2022 for improving jawline definition.1 Our Radiesse page covers the first.

Temples

Juvederm Voluma XC was approved in 2023 for moderate to severe temple hollowing, and Restylane Contour in March 2026.1 The FDA approved a device-specific training program for the Voluma temple use in 2024. In September 2026 it approved Restylane Contour labeling stating that, for temple hollowing, the product is distributed only to providers who have completed device-specific training.1

Areas and the products the FDA record names

AreaProducts named in the FDA recordAge in the record
CheeksProducts named in the FDA record: Juvederm Voluma XC, Restylane Lyft, Restylane Contour, RHA 4, RHA Dynamic VolumeAge in the record: Adults 22 and older
ChinProducts named in the FDA record: Juvederm Voluma XC, Restylane Defyne, Restylane LyftAge in the record: Adults 22 and older
JawlineProducts named in the FDA record: Radiesse (+), Juvederm Volux XCAge in the record: Adults 22 and older
TemplesProducts named in the FDA record: Juvederm Voluma XC, Restylane ContourAge in the record: Adults 22 and older

The record's wording is "over the age of 21" for most of these, and "22 or older" for the RHA products. The FDA's consumer update says fillers are approved for specific uses in people aged 22 and older.12 This is the FDA's record of approvals, not a complete list of every product that may be approved for each area, so check your product.

Risks

Common risks are bruising, redness, swelling, pain, tenderness, itching and rash. Most appear shortly after injection and many resolve in days to weeks, though in some cases side effects emerge weeks, months or years later.2

The most serious risk is accidental injection into a blood vessel. The FDA says that can cause skin necrosis (death of tissue), stroke or blindness, and that while the chance is low, the complications can be serious and may be permanent.2 Filler can also be hard to take back: reducing or removing it may need further injections or surgery, and for some materials it may be difficult or impossible.2

Myth

A filler approved for the lips can be used anywhere on the face.

Fact

The FDA approves each filler for specific uses. Cheek, chin, jawline and temple approvals are separate, and the FDA now limits one temple filler to providers who completed device-specific training.

FDA PMA database: filler approval statements, read 30 Oct 2026FDA, Dermal Filler Do's and Don'ts for Wrinkles, Lips and More, read 30 Oct 2026

Which licensed professionals may inject depends on your state. See our guide to choosing a lip filler provider, whose checks apply to any filler, and our dermal filler overview.

Here is what to bring to a consultation.

Questions to bring

The product

The person and the plan

0 of 6 ticked

Cost

We don't give prices on this page. Our lip filler cost guide shows how clinics quote filler, per syringe.

Find clinics

Each listing shows what the clinic’s own website offers, its Google reviews and its hours. No clinic is graded yet.

Common questions

Which fillers are approved for cheeks?

The FDA's record names Juvederm Voluma XC, Restylane Lyft, Restylane Contour, and RHA 4 and RHA Dynamic Volume for cheek augmentation. It also lists Sculptra for cheek wrinkles and Bellafill for cheek acne scars.

Which fillers are approved for the jawline?

Radiesse (+), approved in 2021, and Juvederm Volux XC, approved in 2022.

Which fillers are approved for the temples?

Juvederm Voluma XC, approved in 2023, and Restylane Contour, approved in March 2026. The FDA limits Restylane Contour's temple use to providers who completed device-specific training.

What is the biggest risk of cheek or jawline filler?

Accidental injection into a blood vessel. The FDA says it can cause tissue death, stroke or blindness. The chance is low, but the complications can be serious and permanent.

Sources (2)

  1. FDA PMA database: Juvederm family (P110033), Restylane family (P040024, P140029), RHA (P170002), Radiesse (P050052), Sculptra (P030050), Bellafill (P020012), approval and supplement history · US Food and Drug Administration, premarket approval database. Read on 30 Oct 2026: the approval statements on each record, not the product labeling. · read 30 Oct 2026
  2. FDA, Dermal Filler Do's and Don'ts for Wrinkles, Lips and More · US Food and Drug Administration (content current as of 07/07/2023 per the page) · read 30 Oct 2026

Where to go next